Background-The innate immune system greatly contributes to the inflammatory process after myocardial infarction (MI).
T he innate immune system is evolutionarily conserved among all multicellular organisms and is the first line of defense against microorganisms through Toll-interleukin-1 receptor (TIR) signaling. However, this system is also activated after various forms of tissue injury and triggers immune responses in the host. 1 We and others have demonstrated that the innate immune system contributes importantly to the progression of myocarditis and the remodeling process after myocardial infarction (MI). [2] [3] [4] 
Clinical Perspective on p 1414
Toll-like receptors (TLRs) are type I transmembrane proteins with an extracellular domain containing a leucine-rich repeat and a cytoplasm domain analogous to those of members of the interleukin (IL)-1 receptor family. 5 After ligand binding, TLRs and IL-1 receptors dimerize and undergo a conformational change required for the recruitment of common downstream signaling molecules. These include the adaptor molecule myeloid differentiation primary-response protein 88, IL-1 receptor-associated kinases (IRAKs), and tumor necrosis factor (TNF) receptor-associated factor 6 and ultimately lead to translocation of nuclear factor B (NF-B) for the production of proinflammatory cytokines. IRAK-4, a member of the IRAK family and a downstream protein of TIR signaling, has been shown to play an essential role in mediating signals initiated by IL-1 receptor and TLR engagement. 6 Dendritic cells (DCs) are a sparsely distributed, migratory group of bone marrow (BM) -derived leukocytes that are major antigen-presenting cells and key players in regulating the innate immune responses through TIR signaling. They have been found in lymphoid and nonlymphoid organs, including heart, liver, thyroid, pancreas, bladder, kidney, ureter, and skin. 7, 8 DCs and their precursors are considered sentinels of the immune system; they circulate through the blood and nonlymphoid peripheral tissues, where they become resident cells over time. 9 After pathogen invasion or tissue injury, DC precursors accumulate rapidly in the local infected tissues. 10 Zhang et al 11 showed that migrating BMderived DCs (BMDCs) infiltrate into the injured myocardium and participate in the activation of lymphocytes after MI. A recent study demonstrated that DCs regulate the development of autoimmune heart failure through the recognition of heart-specific peptides. 12 These observations suggest that DCs may play a role in inflammation and consequently in tissue remodeling after MI.
Although in vivo experiments have shown a cardioprotective effect by inhibition of the innate immune response after MI, 4, 13 the mechanism remains to be identified. To clarify potential mechanisms, we designed the following experiments to answer these questions: Is deletion of IRAK-4, a downstream molecule of TIR signaling, protective against myocardial ischemia? If so, how does IRAK-4 deficiency lead to a favorable host outcome after MI? In the present study, we used IRAK-4 Ϫ/Ϫ mice combined with adoptive transfer and demonstrated that attenuation of TIR signaling and DC function contributed to protecting the heart against MI.
Methods
A detailed Methods section can be found in the online-only Data Supplement.
Experimental Animals
Generation of IRAK-4 Ϫ/Ϫ mice with a mixed 129/Ola;B6 genetic background has been described previously. 14 After mating, homozygous (Ϫ/Ϫ) and wild-type (ϩ/ϩ) (WT) mice were identified by polymerase chain reaction analysis of DNA obtained from the tail of each mouse, and male homozygous and WT mice were used in this experiment. All procedures were performed in accordance with the Animal Care Committee of the University Health Network of University of Toronto. All mice were housed under identical conditions and given food and water ad libitum.
Adoptive DC Transfer
BMDCs (1ϫ10 6 cells per mouse) from WT or IRAK-4 Ϫ/Ϫ mice were resuspended in 40 L PBS and then injected into the border zone of myocardium after MI. We confirmed reconstituted BMDCs, which were labeled with the fluorescent dye 5, 6-carboxyfluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes, Carlsbad, Calif) according to the manufacturer's protocol, in WT or IRAK-4 Ϫ/Ϫ mice under the fluorescent microscope in combination with ␣-actinin (Sigma-Aldrich, St Louis, Mo) staining.
Additional Methods
The expanded Methods section in the online-only Data Supplement contains information on the creation of MI; hemodynamic measurements; echocardiographic and morphometric analyses; DC isolation from BM; in vitro activation of BMDCs; isolation of DCs from the heart; flow cytometry; Western blotting; immunohistochemistry; analysis of myocardial apoptosis; electrophoretic mobility shift assay; TNF-␣, IL-6, and IL-12p70 measurements; and quantification of gene expression by real-time polymerase chain reaction.
Statistical Analyses
All values are presented as meanϮSEM. Analyses of data recorded at a single time point were performed by 2-tailed unpaired Student t tests. IRAK-4 expression over time was compared by use of 1-way ANOVA for repeated measurements with posthoc testing. Comparison of expression levels between IRAK-4 Ϫ/Ϫ and WT mice was performed with 2-way ANOVA with posthoc testing. Percentages of DCs were compared by use of 2-way ANOVA for repeated measurements and posthoc testing. Survival rates were compared by the Kaplan-Meier method and analyzed by the log-rank test. Significance was taken as PϽ0.05. All statistical analyses were performed with Statview 5.0 software (SAS Institute Inc, Cary, NC) and Microsoft Office Excel (Microsoft, Redmond, Wash).
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results

Expression of IRAK-4 in the Infarcted Myocardium
We analyzed the IRAK-4 protein level in the infarcted myocardium by immunoblotting. IRAK-4 expression in WT mice was upregulated within 7 days after MI, suggesting that it is a stress-induced protein involved in myocardial inflammation ( Figure 1A and 1B).
Improved Survival and Cardiac Function in IRAK-4 ؊/؊ Mice After MI
All sham-operated mice survived throughout the study. Survival was significantly higher in IRAK-4 Ϫ/Ϫ (76%) compared with WT (36%) mice on day 28 after MI ( Figure 1C ). Echocardiographic analysis revealed decreased cardiac dilatation and better systolic function in IRAK-4 Ϫ/Ϫ compared with WT infarcted hearts at 28 days. Hemodynamic data also showed that left ventricular (LV) end-systolic pressure and dP/dtmax were significantly greater in IRAK-4 Ϫ/Ϫ than WT mice after MI (the Table) . Although there was no significant difference in the ratio of lung weight to body weight between WT and IRAK-4 Ϫ/Ϫ mice, the ratio of heart weight to body weight in IRAK-4 Ϫ/Ϫ mice was significantly lower than in WT mice after MI (the Table) .
Comparisons of Infarct Sizes Between WT and IRAK-4 ؊/؊ Mice
Although the size of the MI on day 3 was similar between WT and IRAK-4 Ϫ/Ϫ mice, the infarct in the mice at 28 days after MI tended to be smaller in IRAK-4 Ϫ/Ϫ than WT mice ( Figure  1D and 1E).
Reduced Infiltration of Leukocytes, CD3 ؉ T Lymphocytes, and CD11c ؉ DCs Into the Injured Myocardium of IRAK-4 ؊/؊ Mice
On day 3, CD45 ϩ leukocyte infiltration into the infarcted site was reduced in IRAK-4 Ϫ/Ϫ mice compared with WT mice. Interestingly, fewer CD3 ϩ T lymphocytes and CD11c ϩ DCs were also observed in the infarcted myocardium of IRAK-4 Ϫ/Ϫ compared with WT mice (Figure 2A through 2C). Infiltrating Mac-3 ϩ macrophages also tended to be fewer in IRAK-4 Ϫ/Ϫ than in WT mice. In contrast, infiltration of neutrophils into the infarcted portion was similar between WT and IRAK-4 Ϫ/Ϫ mice (Figure 2A 
Apoptosis Was Attenuated in IRAK-4 ؊/؊ Mice After MI
The number of apoptotic nuclei as detected by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining was significantly lower in the LV border zone of IRAK-4 Ϫ/Ϫ mice compared with WT mice on day 3 after MI ( Figure 2D and 2E). There was no significant difference in the expression of total caspase-3 between WT and IRAK-4 Ϫ/Ϫ mice; however, the expression of cleaved caspase-3 from the LV border zone was significantly reduced in IRAK-4 Ϫ/Ϫ mice compared with WT mice on day 3 after MI ( Figure 2F and 2G).
Evidence of Fibrosis on Histological Sections
Collagen volume fraction in the noninfarcted zone based on picrosirius red staining was significantly lower in IRAK-4 Ϫ/Ϫ compared with WT mice at 28 days after MI. Fibrosis in the infarcted region tended to be lower in IRAK-4 Ϫ/Ϫ than WT mice ( Figure 3A and 3B).
Inducible Nitric Oxide Synthase Expression in the Injured Myocardium
Inducible nitric oxide (NO) synthase (iNOS) can be upregulated in the ischemic myocardium as part of the innate immune response to tissue injury. iNOS expression and total NO production was attenuated in IRAK-4 Ϫ/Ϫ compared with WT mice after MI ( Figure 4A through 4C). 
Defective IRAK-4 Showed Less Phosphorylation of Inhibitor-B␣, NF-B p65, and c-Jun NH2-Terminal Kinase in the Infarcted Myocardium
IRAK-4 is an integral part of TIR signaling activation, which results in NF-B activation. NF-B activation occurs through the phosphorylation and degradation of inhibitor-B (IB)␣, a protein that binds and retains NF-B in the cytoplasm of resting cells. Phosphorylated inhibitor-B kinase (IKK)␣ and IKK␤ protein expression, the 2 catalytic subunits of IKK important for phosphorylation of I␤␣, was significantly increased in the infarcted site in WT mice after MI. Phosphorylation and degradation of I␤␣ and phosphorylation of NF-B p65 were induced in WT mice but were significantly suppressed in IRAK-4 Ϫ/Ϫ mice ( Figure 5A and 5B). The NF-B-DNA binding activity was attenuated in IRAK-4 Ϫ/Ϫ compared with WT mice after MI ( Figure 5C ). Gene expression of proinflammatory and Th1 cytokines such as IL-1␤, IL-6, TNF-␣, and IL-12 was dramatically decreased in IRAK-4 Ϫ/Ϫ mice after MI ( Figure 5D ). TIR signaling activation also induces mitogen-activated protein kinase pathway activation. The classic mitogen-activated protein kinase signaling pathway comprises 3 major branches named for their terminal effector kinases: the extracellular signal-regulated protein kinases, the c-Jun NH2-terminal kinases (JNK), and p38. The activation of JNK induced by myocardial ischemia was greatly impaired in IRAK-4 Ϫ/Ϫ mice after MI, whereas phosphorylation of p38 and extracellular signal-regulated protein kinase was not diminished in IRAK-4 Ϫ/Ϫ compared with WT mice ( Figure 5E and 5F). These results suggest that IRAK-4 is also critical for the activation of JNK in the TIR signaling after MI.
Difference in Characteristics Between Cardiac DCs From WT and IRAK-4 ؊/؊ Mice After MI
To further investigate the link between the better survival rate and cardiac function in IRAK-4 Ϫ/Ϫ mice with differential inflammatory cell mobilization, we focused on the difference in characteristics of DCs between WT and IRAK-4 Ϫ/Ϫ mice. The number of DCs in the peripheral circulation increased and peaked 3 days after MI in WT mice ( Figure 6A ). DCs can reside in the noninflamed heart, and the population of DCs in the infarcted myocardium expands after MI. Although our data confirmed that there are some DCs in the heart under resting conditions (0.16%), surprisingly, the DC population in the heart after MI expanded very significantly to 3.66% ( Figure 6B through 6D). However, this was reduced in the IRAK-4 Ϫ/Ϫ hearts. Light microscopy also showed morphological changes in DCs from WT mice after MI compared with after sham operation ( Figure 6E ). Expression of CD80 and CD86, which are DC maturation markers, was much higher in WT-than IRAK-4 Ϫ/Ϫ -derived cardiac DCs after MI. Similarly, cytokine gene expression such as IL-6, TNF-␣, IL-12a, and IL-12b markedly increased in WT but not in IRAK-4 Ϫ/Ϫ cardiac DCs ( Figure 6F ). These findings suggest that in contrast to WTderived cardiac DCs, IRAK-4 Ϫ/Ϫ cardiac DCs have an impaired maturation process after ischemia and a decreased ability to produce proinflammatory and Th1 cytokines. 
Characteristics of BMDCs From WT and IRAK-4 ؊/؊ Mice
To further characterize the mobilized DCs after MI, we compared BMDCs from WT and IRAK-4 Ϫ/Ϫ mice in response to several endogenous ligands. Expression of CD80, CD86, and major histocompatibility complex class II, which are DC maturation markers, increased in BMDCs of WT mice after lipopolysaccharide stimulation, but this was blunted in IRAK-4 Ϫ/Ϫ mice. On the other hand, heat shock protein (HSP)-70, an endogenous ligand for TIR signaling, did not upregulate these markers on BMDCs in either WT or IRAK-4 Ϫ/Ϫ mice ( Figure 7A and 7B). BMDCs from WT mice showed robust proinflammatory and Th1 cytokine production to lipopolysaccharide, HSP70, and necrotic cell supernatants from HL-1 (cardiomyocytes) and mouse embryonic fibroblasts containing HSP70 ( Figure 7D ), but BMDCs from IRAK-4 Ϫ/Ϫ mice displayed a markedly blunted cytokine production and gene expression ( Figure 7C and 7E) . These findings suggest that HSP70 induced not phenotypic but functional DC maturation. Additionally, using several strategies, including addition of polymyxin B to the culture medium and heat inactivation of the recombinant protein, we confirmed that in vitro observations were attributable to the actions of HSP70 and not contaminants such as lipopolysaccharide. Mature DCs not only can produce more cytokines but also can induce T-lymphocyte proliferation. Compared with WT-derived BMDCs, IRAK-4 Ϫ/Ϫ -derived BMDCs have less ability to proliferate allogeneic CD4 ϩ T lymphocytes ( Figure 7F ). Taken together, BMDCs from IRAK-4 Ϫ/Ϫ mice have less ability to produce cytokines in response to endogenous ligands of TIR and to proliferate T lymphocytes compared with BMDCs from WT mice.
IRAK-4 ؊/؊ DCs Have Less Mobilization Capacity In Vivo
To compare IRAK-4 Ϫ/Ϫ DC with WT DC mobilization capacity in vivo, we analyzed mobilized DCs in the spleen after cytokine treatment. The number of CD11c ϩ CD11b ϩ DCs was significantly lower in the spleen of IRAK-4 Ϫ/Ϫ mice compared with WT mice on day 7 after cytokine treatment, although the number of CD11c ϩ CD11b ϩ DCs in the spleen was similar between WT and IRAK-4 Ϫ/Ϫ mice after PBS treatment ( Figure 7G and 7H) . These findings indicate that IRAK-4 Ϫ/Ϫ myeloid DCs have less mobilization capacity in vivo compared with WT myeloid DCs.
IRAK-4 ؊/؊ BMDCs Have Less Migration Ability
To clarify the mechanism of the difference in DC migration between WT and IRAK-4 Ϫ/Ϫ mice, we evaluated chemokine expression in the infarcted heart and DC migration to DCrelated chemokines. Chemokine (C-C motif) ligand 5 (CCL5) expression in the infarcted heart was lower in IRAK-4 Ϫ/Ϫ mice ( Figure 
Adoptive Transfer of BMDCs From WT to IRAK-4 ؊/؊ Mice
Our data indicate that the failure to induce proinflammatory and Th1 cytokine production in IRAK-4 Ϫ/Ϫ DCs is due in part to defective functional DC maturation. To prove that this is the key factor affecting survival rate and the remodeling process after MI, we performed an adoptive transfer experiment using WT DCs. 8A). In contrast, the survival rate of WT recipient mice was not altered after transfer (WT without WT-derived BMDCs, 36%; WT with WT-derived BMDCs, 31%; Figures 1C and  8A ). All sham-operated mice with BMDCs survived during the 4 weeks after MI. CFSE-labeled DCs were distributed equally in the heart of WT and IRAK-4 Ϫ/Ϫ mice after transfer ( Figure 8B ). To evaluate the influence of procedures themselves on results, we also performed PBS injection into WT or IRAK-4 Ϫ/Ϫ mice after MI. The survival rate was similar between WT or IRAK-4 Ϫ/Ϫ mice with PBS injection and without injection after MI ( Figures 1C and 8A) . The survival rate of IRAK-4 Ϫ/Ϫ recipient mice was unchanged after transfer of IRAK-4 Ϫ/Ϫ -derived BMDCs ( Figure 8A ). In addition to the decrease in survival rate, there was no significant difference in the ratio of heart weight to body weight between WT and IRAK-4 Ϫ/Ϫ mice after the transfer of WT-derived BMDCs, although the ratio of heart weight to body weight in IRAK-4 Ϫ/Ϫ mice was smaller than in WT mice at 28 days after MI (the Table and Figure 8C ). The LV end-systolic dimension and fractional shortening were also comparable between WT and IRAK-4 Ϫ/Ϫ mice after the transfer of WT-derived BMDCs at 28 days after MI ( Figure 8D ). These results indicated that DCs themselves can influence survival rate and cardiac morphology through modulating the inflammatory process after MI.
Discussion
The present study demonstrated that IRAK-4 Ϫ/Ϫ mice had a higher survival rate and improved function and remodeling through decreased inflammation resulting from the blunted innate immune response after MI. This was mediated mainly through the inability of BMDCs to mobilize, mature, and produce cytokines in the IRAK-4 Ϫ/Ϫ mice. The adoptive transfer of WT-derived mature BMDCs into IRAK-4 Ϫ/Ϫ mice decreased the survival advantage and worsened the cardiac remodeling of IRAK-4 Ϫ/Ϫ mice after MI such that they were indistinguishable from WT controls. This finding suggests that the innate immune system activation and IRAK-4 signaling were crucial for BMDC mobilization and maturation, contributing to post-MI mortality and adverse remodeling. Inflammatory response and cytokine elaboration play a particularly active role after MI; in turn, the degree of the inflammatory response is an important determinant of the outcome of the host. 15 In IRAK-4 Ϫ/Ϫ mice, attenuation of TIR signaling resulted in lower expression of cytokines and decreased inflammation through blunted innate immune response. Previous reports suggested that proinflammatory cytokines induce cardiomyocyte apoptosis and cardiac fibrosis and positively correlate with iNOS expression. 16, 17 Consistent with these findings, the present study demonstrated increased cardiomyocyte apoptosis and cardiac fibrosis in the noninfarcted myocardium and higher iNOS expression and elevated total NO production in WT but not IRAK-4 Ϫ/Ϫ mice. NF-B is a key transcription factor that regulates inflammatory processes and greatly contributes to the pathophysiology of MI. Inhibition of NF-B by a knockout model and pharmacological approach showed improvement in survival and cardiac function after MI. 18, 19 Consistent with those studies, we showed attenuation of NF-B activity in IRAK-4 Ϫ/Ϫ mice, which was associated with lower proinflammatory and Th1 cytokine gene expression and thus better a survival rate and hemodynamics after MI. On the other hand, a previous study showed that NF-B protects the adult cardiac myocyte against myocardial ischemia. 20 Dichotomous findings reflect the overall experimental design itself, which highlights the complexity intrinsic to NF-B signaling pathways and their dependency on specific conditions. However, our results showed that not only NF-B but also JNK activation was severely impaired in IRAK-4 Ϫ/Ϫ mice after MI. JNK is also activated after MI, and inhibition of JNK inhibits IL-6 transcription. 21 Accordingly, we provide evidence that the attenuation of NF-B and JNK activity in IRAK-4 Ϫ/Ϫ mice resulted in decreased inflammation and thus improved host outcome after MI. In our study, HSP70, which is one of the endogenous ligands, was highly expressed in the infarcted heart (data not shown), and cardiac DCs showed upregulation of IL-1␤, IL-6, TNF-␣, and IL-12 in WT mice after MI. It is tempting to speculate that in response to the danger signal HSP70 released by necrotic myocardium, cardiac DCs become activated and can upregulate proinflammatory and Th1 cytokine expression. Our in vitro results showed that BMDCs from WT mice produced a significant amount of inflammatory cytokines in response to HSP70 and necrotic cell supernatants. Importantly, the present in vitro results are consistent with several studies that have shown that HSP70 activates BMDCs and induces proinflammatory and Th1 cytokine production through the activation of TLR2 and TLR4 signaling and that dying cells can activate DCs, thus causing "sterile inflammation." [22] [23] [24] In contrast, BMDCs from IRAK-4 Ϫ/Ϫ mice were severely impaired in their ability to produce proinflammatory and Th1 cytokines. Furthermore, IRAK-4 Ϫ/Ϫ DCs have less mobilization capacity in vivo, which is closely associated with the reduced number of DCs infiltrating into the infarcted heart in IRAK-4 Ϫ/Ϫ mice. These results suggest that deficiency in IRAK-4 led to not only reduced DC mobilization but also a blunted response in mobilized BMDCs when triggered with the endogenous ligands and thus prevented DC activation under myocardial ischemia.
DCs constitutively express cardiac self-antigens on major histocompatibility complex class II molecules even in the normal heart, 25 and some patients have cardiac-specific autoimmune response after MI. 26 Furthermore, Göser et al 27 showed that mice preimmunized with murine cardiac troponin I displayed greater infarct size, more fibrosis, higher inflammation score, and cardiac dysfunction after MI. These findings indicate that myocardial damage results in release of not only endogenous ligands of TLRs but also self-antigens. If self-antigen-loaded DCs become activated via TLR stim- ulation by endogenous ligands after MI, this might be sufficient for the initiation of an autoimmune response. Several studies showed that activated T lymphocytes infiltrate into infarcted and noninfarcted myocardium after MI. 26, 28 DC activation mediated by TLRs and thereafter direct interaction between activated DCs and T lymphocytes are required before T-lymphocyte activation. Yang et al 29 showed that CD4 ϩ T lymphocytes are activated early during reperfusion and contribute to an early inflammatory response in myocardial reperfusion injury. These findings support our results that CD80 and CD86 are expressed on cardiac DCs upregulated in WT mice after MI because CD80 and CD86 upregulation is required for activation of naïve T lymphocytes. 7 In IRAK-4 Ϫ/Ϫ mice, cardiac DCs had lower expression of CD80 and CD86 genes after MI and BMDCs had less ability to proliferate CD4 ϩ T lymphocytes, indicating that decreased inflammation in the infarcted myocardium of IRAK-4 Ϫ/Ϫ mice may be associated with decreased T-lymphocyte activation. Unlike autoimmune myocarditis, further investigation is needed to determine to what extent autoimmune response contributes to the inflammatory process after MI, although autoreactive CD3 ϩ T lymphocytes were observed and Th1 not Th17 T-cell response was predominant in our model (data not shown). However, autoimmunity may be one of the possible mechanisms by which DCs affect the inflammatory process after MI, and some clinical and experimental observations support this mechanism. 26, 30, 31 
Conclusions
The present findings are the first to demonstrate a critical role for IRAK-4 in survival and cardiac remodeling and the importance of DCs in the inflammatory process after MI. IRAK-4 could be a potential target for the treatment of patients with post-MI heart failure. 
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